Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in

Le T Luan1, Nguyen V Trang, Nguyen M Phuong

  • 1Center for Research and Production of Vaccines and Biologicals (POLYVAC), 135 Loduc Street, Hai Ba Trung, Hanoi, Viet Nam. luanpolyvac@gmail.com

Vaccine
|November 26, 2009
PubMed

Insights

Vietnam is developing its own rotavirus vaccine to prevent diarrhoea in young children. This initiative aims for self-sufficiency in vaccine production, using locally isolated rotavirus strains for a new G1P[8] vaccine.

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • Rotavirus infection is a leading cause of hospitalization for diarrhoea in Vietnamese children under five.
  • Introducing new vaccines into Vietnam's immunization schedule presents challenges for developing countries.
  • Vietnam aims for partial self-sufficiency in vaccine production through domestic development.

Purpose of the Study:

  • To describe the isolation and characterization of three human rotavirus strains from Vietnamese children.
  • To identify candidate strains for developing a Vietnamese rotavirus vaccine.
  • To support the development of a monovalent G1P[8] rotavirus vaccine using a Vietnamese-derived strain.

Main Methods:

  • Isolation of human rotavirus strains from children with diarrhoea in Vietnam.
  • Characterization of the isolated rotavirus strains.
  • Multiple passages in cell culture for natural attenuation of candidate strains.

Main Results:

  • Three human rotavirus strains were successfully isolated and characterized.
  • These strains are considered candidates for further rotavirus vaccine development in Vietnam.
  • The study outlines a strategy for a monovalent G1P[8] vaccine using a Vietnamese isolate.

Conclusions:

  • Vietnam is actively pursuing the development of indigenous rotavirus vaccine candidates.
  • The project aims to achieve greater self-sufficiency in vaccine production.
  • Lessons learned will improve overall vaccine manufacturing quality, including the use of Vero cell techniques for other vaccines.